BACKGROUND: Galectin-3 is expressed in the synovial tissue of patients with rheumatoid arthritis (RA), particularly at sites of joint destruction. OBJECTIVE: To explore the possibilities that galectin-3 is induced either by proinflammatory cytokines or by adhesion to cartilage components. METHODS: Cell culture plates were coated with fibronectin, collagens I-VI, or cartilage oligomeric matrix protein (COMP), and the suspended cells were then added. The medium was changed after 1 hour at 37 degrees C. Adherent cells were further incubated for 18 hours in the presence or absence of tumour necrosis factor alpha (TNF alpha) or interleukin 1 beta. Cells were pretreated with murine IgG1, anti-CD29, -CD51, -CD61 (integrins), or -CD3 monoclonal antibodies and transferred to culture plates coated with COMP. Adherent cells were counted by light microscopy. The expression of intracellular galectin-3, or cell surface CD29, CD51, and CD61 was determined by flow cytometry before and after adhesion. RESULTS: Four times more RA synovial fibroblasts (SF) than osteoarthritis SF adhered to COMP. RA SF presented more cell surface integrins, and monoclonal antibodies against CD51 inhibited the adhesion to COMP by 80%. TNF alpha reduced the expression of CD61 and the adhesion to COMP, but did not reverse the adhesion once it had taken place. The adhesion of RA SF to COMP was found to increase the intracellular level of galectin-3. In contrast, intracellular galectin-3 decreased after exposure to TNF alpha. CONCLUSION: The increase of galectin-3 occurs after adhesion to COMP, and the alpha V beta 3 receptor (CD51/CD61) has a pivotal role in this process.
BACKGROUND:Galectin-3 is expressed in the synovial tissue of patients with rheumatoid arthritis (RA), particularly at sites of joint destruction. OBJECTIVE: To explore the possibilities that galectin-3 is induced either by proinflammatory cytokines or by adhesion to cartilage components. METHODS: Cell culture plates were coated with fibronectin, collagens I-VI, or cartilage oligomeric matrix protein (COMP), and the suspended cells were then added. The medium was changed after 1 hour at 37 degrees C. Adherent cells were further incubated for 18 hours in the presence or absence of tumour necrosis factor alpha (TNF alpha) or interleukin 1 beta. Cells were pretreated with murine IgG1, anti-CD29, -CD51, -CD61 (integrins), or -CD3 monoclonal antibodies and transferred to culture plates coated with COMP. Adherent cells were counted by light microscopy. The expression of intracellular galectin-3, or cell surface CD29, CD51, and CD61 was determined by flow cytometry before and after adhesion. RESULTS: Four times more RA synovial fibroblasts (SF) than osteoarthritis SF adhered to COMP. RA SF presented more cell surface integrins, and monoclonal antibodies against CD51 inhibited the adhesion to COMP by 80%. TNF alpha reduced the expression of CD61 and the adhesion to COMP, but did not reverse the adhesion once it had taken place. The adhesion of RA SF to COMP was found to increase the intracellular level of galectin-3. In contrast, intracellular galectin-3 decreased after exposure to TNF alpha. CONCLUSION: The increase of galectin-3 occurs after adhesion to COMP, and the alpha V beta 3 receptor (CD51/CD61) has a pivotal role in this process.
Authors: Christian A Seemayer; Stefan Kuchen; Peter Kuenzler; Veronika Rihosková; Janine Rethage; Wilhelm K Aicher; Beat A Michel; Renate E Gay; Diego Kyburz; Michel Neidhart; Steffen Gay Journal: Am J Pathol Date: 2003-05 Impact factor: 4.307
Authors: Shiro Ohshima; Stefan Kuchen; Christian A Seemayer; Diego Kyburz; Astrid Hirt; Stephanie Klinzing; Beat A Michel; Renate E Gay; Fu-Tong Liu; Steffen Gay; Michel Neidhart Journal: Arthritis Rheum Date: 2003-10
Authors: David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman Journal: Antioxid Redox Signal Date: 2019-03-29 Impact factor: 8.401
Authors: Maik Hoberg; Maximilian Rudert; Thomas Pap; Gerd Klein; Steffen Gay; Wilhelm K Aicher Journal: Ann Rheum Dis Date: 2006-11-23 Impact factor: 19.103
Authors: Scott A Barman; Xueyi Li; Stephen Haigh; Dmitry Kondrikov; Keyvan Mahboubi; Zsuzsanna Bordan; David W Stepp; Jiliang Zhou; Yusi Wang; Daniel S Weintraub; Peter Traber; William Snider; Danny Jonigk; Jennifer Sullivan; G Ryan Crislip; Joshua T Butcher; Jennifer Thompson; Yunchao Su; Feng Chen; David J R Fulton Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-02-06 Impact factor: 5.464
Authors: Olga Frunza; Ilaria Russo; Amit Saxena; Arti V Shinde; Claudio Humeres; Waqas Hanif; Vikrant Rai; Ya Su; Nikolaos G Frangogiannis Journal: Am J Pathol Date: 2016-03-03 Impact factor: 4.307
Authors: Andrew Filer; Magdalena Bik; Greg N Parsonage; John Fitton; Emily Trebilcock; Katherine Howlett; Michelle Cook; Karim Raza; David L Simmons; Andrew M C Thomas; Mike Salmon; Dagmar Scheel-Toellner; Janet M Lord; Gabriel A Rabinovich; Christopher D Buckley Journal: Arthritis Rheum Date: 2009-06
Authors: Ingo Ahrens; Helena Domeij; Denijal Topcic; Izhak Haviv; Ruusu-Maaria Merivirta; Alexander Agrotis; Ephraem Leitner; Jeremy B Jowett; Christoph Bode; Martha Lappas; Karlheinz Peter Journal: PLoS One Date: 2011-08-12 Impact factor: 3.240